Please assess the completion status of the following clinical trial:

Trial Title: Hypogonadotropic Hypogonadism in Obese Young Males

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Males~* Age 18-30 years inclusive will be recruited.~A total of 90 males will be recruited:-~* 30 obese males (defined as BMI ≥30 kg/m2) with HH,~* 30 obese males with normal FT concentrations and~* 30 lean males (defined as BMI \<25 kg/m2) with normal FT concentrations.~Exclusion Criteria:~* Use of androgens, clomiphene, hCG, aromatase inhibitors or over the counter health supplements which contain androgens currently or in the past 6 months~* Hematocrit \> 50%~* Congestive heart failure~* currently suffering from depression~* type 1 diabetes~* Hepatic disease (transaminase \> 3 times normal) or cirrhosis~* Renal impairment (eGFR\<30 ml/min/1.73m2)~* HIV or Hepatitis C positive status~* Participation in any other concurrent clinical trial~* currently suffering from foot ulcer, significant periodontal disease or any other chronic infectious condition

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Obese males with hypogonadism-active (Type: ACTIVE_COMPARATOR): Subjects will be randomized to receive clomiphene capsules
- Obese males with hypogonadism-placebo (Type: PLACEBO_COMPARATOR): Subjects will be randomized to receive placebo capsules
- Obese males with normal testosterone (Type: NO_INTERVENTION): comparison group
- lean males with normal testosterone (Type: NO_INTERVENTION): comparison group

Based on this trial design, predict the completion outcome and termination type (if applicable).